A DNA binding mutation in estrogen receptor-α Leads to suppression of Wnt signaling via β-catenin destabilization in osteoblasts

Ulrike I. Mödder, Volha Rudnik, Gang Liu, Sundeep Khosla, David G Monroe

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Estrogen receptors (ERs) play vital roles in the function and remodeling of bone. Their cellular mechanisms can broadly be categorized into those involving direct DNA binding (classical) or indirect DNA binding (non-classical). The generation of non-classical ER knock-in (ERα-/NERKI) mice provides a unique opportunity to define these pathways in bone. We previously demonstrated that ERα-/NERKI mice exhibit an osteoporotic phenotype; however, the mechanism(s) for this remain unresolved. Gene expression analyses of cortical bone from ERα-/NERKI mice revealed suppression of lymphoid enhancer factor-1 (Lef1), a classic Wnt-responsive transcription factor that associates with β-catenin. Since Wnt signaling is generally considered bone anabolic, this observation leads to the hypothesis that NERKI-induced suppression of Wnt signaling may contribute to the low bone mass phenotype. We generated ERα-/NERKI mice crossed with the Wnt-responsive TOPGAL transgenic mouse model and observed significantly less β-galactosidase activity in ERα-/NERKI mice, confirming suppression of Wnt activity in vivo. Adenoviral expression of the NERKI receptor using an in vitro cell system resulted in the induction of several secreted antagonists of Wnt signaling. Furthermore, expression of NERKI abrogated Wnt10b-dependent Wnt activation using a lentiviral-mediated reporter assay. Finally, expression of NERKI destabilized β-catenin cellular protein levels and disrupted ER/β-catenin interactions. Collectively, these data suggest the osteoporotic phenotype of ERα-/NERKI mice may involve the suppression of Lef1-mediated Wnt signaling through both the stimulation of secreted Wnt inhibitors and/or disruption of normal β-catenin function.

Original languageEnglish (US)
Pages (from-to)2248-2255
Number of pages8
JournalJournal of Cellular Biochemistry
Volume113
Issue number7
DOIs
StatePublished - Jul 2012

Fingerprint

Catenins
Osteoblasts
Estrogen Receptors
Mutation
DNA
Bone
TCF Transcription Factors
Bone and Bones
Galactosidases
Phenotype
Bone Remodeling
Gene expression
Transgenic Mice
Assays
Transcription Factors
Chemical activation
Gene Expression

Keywords

  • β-catenin
  • bone
  • Estrogen receptor
  • nerki
  • Wnt

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

A DNA binding mutation in estrogen receptor-α Leads to suppression of Wnt signaling via β-catenin destabilization in osteoblasts. / Mödder, Ulrike I.; Rudnik, Volha; Liu, Gang; Khosla, Sundeep; Monroe, David G.

In: Journal of Cellular Biochemistry, Vol. 113, No. 7, 07.2012, p. 2248-2255.

Research output: Contribution to journalArticle

@article{a99b9c31280345099ae5433edf0cb822,
title = "A DNA binding mutation in estrogen receptor-α Leads to suppression of Wnt signaling via β-catenin destabilization in osteoblasts",
abstract = "Estrogen receptors (ERs) play vital roles in the function and remodeling of bone. Their cellular mechanisms can broadly be categorized into those involving direct DNA binding (classical) or indirect DNA binding (non-classical). The generation of non-classical ER knock-in (ERα-/NERKI) mice provides a unique opportunity to define these pathways in bone. We previously demonstrated that ERα-/NERKI mice exhibit an osteoporotic phenotype; however, the mechanism(s) for this remain unresolved. Gene expression analyses of cortical bone from ERα-/NERKI mice revealed suppression of lymphoid enhancer factor-1 (Lef1), a classic Wnt-responsive transcription factor that associates with β-catenin. Since Wnt signaling is generally considered bone anabolic, this observation leads to the hypothesis that NERKI-induced suppression of Wnt signaling may contribute to the low bone mass phenotype. We generated ERα-/NERKI mice crossed with the Wnt-responsive TOPGAL transgenic mouse model and observed significantly less β-galactosidase activity in ERα-/NERKI mice, confirming suppression of Wnt activity in vivo. Adenoviral expression of the NERKI receptor using an in vitro cell system resulted in the induction of several secreted antagonists of Wnt signaling. Furthermore, expression of NERKI abrogated Wnt10b-dependent Wnt activation using a lentiviral-mediated reporter assay. Finally, expression of NERKI destabilized β-catenin cellular protein levels and disrupted ER/β-catenin interactions. Collectively, these data suggest the osteoporotic phenotype of ERα-/NERKI mice may involve the suppression of Lef1-mediated Wnt signaling through both the stimulation of secreted Wnt inhibitors and/or disruption of normal β-catenin function.",
keywords = "β-catenin, bone, Estrogen receptor, nerki, Wnt",
author = "M{\"o}dder, {Ulrike I.} and Volha Rudnik and Gang Liu and Sundeep Khosla and Monroe, {David G}",
year = "2012",
month = "7",
doi = "10.1002/jcb.24095",
language = "English (US)",
volume = "113",
pages = "2248--2255",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "7",

}

TY - JOUR

T1 - A DNA binding mutation in estrogen receptor-α Leads to suppression of Wnt signaling via β-catenin destabilization in osteoblasts

AU - Mödder, Ulrike I.

AU - Rudnik, Volha

AU - Liu, Gang

AU - Khosla, Sundeep

AU - Monroe, David G

PY - 2012/7

Y1 - 2012/7

N2 - Estrogen receptors (ERs) play vital roles in the function and remodeling of bone. Their cellular mechanisms can broadly be categorized into those involving direct DNA binding (classical) or indirect DNA binding (non-classical). The generation of non-classical ER knock-in (ERα-/NERKI) mice provides a unique opportunity to define these pathways in bone. We previously demonstrated that ERα-/NERKI mice exhibit an osteoporotic phenotype; however, the mechanism(s) for this remain unresolved. Gene expression analyses of cortical bone from ERα-/NERKI mice revealed suppression of lymphoid enhancer factor-1 (Lef1), a classic Wnt-responsive transcription factor that associates with β-catenin. Since Wnt signaling is generally considered bone anabolic, this observation leads to the hypothesis that NERKI-induced suppression of Wnt signaling may contribute to the low bone mass phenotype. We generated ERα-/NERKI mice crossed with the Wnt-responsive TOPGAL transgenic mouse model and observed significantly less β-galactosidase activity in ERα-/NERKI mice, confirming suppression of Wnt activity in vivo. Adenoviral expression of the NERKI receptor using an in vitro cell system resulted in the induction of several secreted antagonists of Wnt signaling. Furthermore, expression of NERKI abrogated Wnt10b-dependent Wnt activation using a lentiviral-mediated reporter assay. Finally, expression of NERKI destabilized β-catenin cellular protein levels and disrupted ER/β-catenin interactions. Collectively, these data suggest the osteoporotic phenotype of ERα-/NERKI mice may involve the suppression of Lef1-mediated Wnt signaling through both the stimulation of secreted Wnt inhibitors and/or disruption of normal β-catenin function.

AB - Estrogen receptors (ERs) play vital roles in the function and remodeling of bone. Their cellular mechanisms can broadly be categorized into those involving direct DNA binding (classical) or indirect DNA binding (non-classical). The generation of non-classical ER knock-in (ERα-/NERKI) mice provides a unique opportunity to define these pathways in bone. We previously demonstrated that ERα-/NERKI mice exhibit an osteoporotic phenotype; however, the mechanism(s) for this remain unresolved. Gene expression analyses of cortical bone from ERα-/NERKI mice revealed suppression of lymphoid enhancer factor-1 (Lef1), a classic Wnt-responsive transcription factor that associates with β-catenin. Since Wnt signaling is generally considered bone anabolic, this observation leads to the hypothesis that NERKI-induced suppression of Wnt signaling may contribute to the low bone mass phenotype. We generated ERα-/NERKI mice crossed with the Wnt-responsive TOPGAL transgenic mouse model and observed significantly less β-galactosidase activity in ERα-/NERKI mice, confirming suppression of Wnt activity in vivo. Adenoviral expression of the NERKI receptor using an in vitro cell system resulted in the induction of several secreted antagonists of Wnt signaling. Furthermore, expression of NERKI abrogated Wnt10b-dependent Wnt activation using a lentiviral-mediated reporter assay. Finally, expression of NERKI destabilized β-catenin cellular protein levels and disrupted ER/β-catenin interactions. Collectively, these data suggest the osteoporotic phenotype of ERα-/NERKI mice may involve the suppression of Lef1-mediated Wnt signaling through both the stimulation of secreted Wnt inhibitors and/or disruption of normal β-catenin function.

KW - β-catenin

KW - bone

KW - Estrogen receptor

KW - nerki

KW - Wnt

UR - http://www.scopus.com/inward/record.url?scp=84861021168&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861021168&partnerID=8YFLogxK

U2 - 10.1002/jcb.24095

DO - 10.1002/jcb.24095

M3 - Article

C2 - 22573547

AN - SCOPUS:84861021168

VL - 113

SP - 2248

EP - 2255

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 7

ER -